An MYB-NFIB and MYB-split-positive status had no or only a weak clinicopathological impact whereas an MYB/MYBL1-split-positive status was associated with a higher tumor grade and a local aggressiveness of the tumor but failed to have a prognostic impact. The gene discussed is MYB; the disease is neoplasm.